Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2001
11/28/2001CN1323833A New polypeptide-human amyloid precursor protein binding protein 51 and polynucleotides for coding same
11/28/2001CN1323832A New polypeptide-human beta-transduced element 14 and polynucleotides for coding same
11/28/2001CN1323830A New polypeptide-human natriuretic peptide acceptor 10 and polynucleotides for coding same
11/28/2001CN1323829A New polypeptide-human ribosomal protein S5-13 and polynucleotides for coding same
11/28/2001CN1323828A New polypeptide-human zinc finger protein 12 and polynucleotides for coding same
11/28/2001CN1323827A New polypeptide-human transcriptional activation protein subunit 14 and polynucleotides for coding same
11/28/2001CN1323826A New polypeptide-human S4 ribosomal protein 10 and polynucleotides for coding same
11/28/2001CN1323825A New polypeptide-human clathrin light chain 9 and polynucleotides for coding same
11/28/2001CN1323824A New polypeptide-human uteroglobin 9 and polynucleotides for coding same
11/28/2001CN1323823A New polypeptide-human beta-microtubulin folding accessory factor C-9 and polynucleotides for coding same
11/28/2001CN1323822A New polypeptide-human central canabis component acceptor 22 and polynucleotides for coding same
11/28/2001CN1323821A New polypeptide-human zinc finger protein 38 and polynucleotides for coding same
11/28/2001CN1323819A New polypeptide-human microglobulin transcription regulating factor 17 and polynucleotides for coding same
11/28/2001CN1323818A New polypeptide-human tumor suppressor factor 14 and polynucleotides for coding same
11/28/2001CN1323816A New polypeptide-human L1 reverse transcription factor 22 and polynucleotides for coding same
11/28/2001CN1323815A New polypeptide-human zinc finger protein 9 and polynucleotides for coding same
11/28/2001CN1323814A New polypeptide-human CCR4 related protein 9 and polynucleotides for coding same
11/28/2001CN1323813A New polypeptide-neural syndesis ion channel related protein 11 and polynucleotides for coding same
11/28/2001CN1323812A New polypeptide-human interleukin-13 (IL-13) receptor 11 and polynucleotides for coding same
11/28/2001CN1323811A New polypeptide-human tumor suppressor factor DPC4 protein 9 and polynucleotides for coding same
11/28/2001CN1323810A New polypeptide-human mitochon dria carrier protein 13 and polynucleotide for coding same
11/28/2001CN1323808A New polypeptide-human sec 13-related protein 10 and polynucleotides for coding same
11/28/2001CN1323807A New polypeptide-human phosphoryl transport protein 12 and polynucleotides for coding same
11/28/2001CN1323806A New polypeptide-human neural cell adhesion protein 31 and polynucleotides for coding same
11/28/2001CN1323805A New polypeptide-human zinc finger protein 15 and polynucleotides for coding same
11/28/2001CN1323804A New polypeptide-human ribosome SII protein 12 and polynucleotides for coding same
11/28/2001CN1323803A New human protein with the function of inhibiting cancer cell growth and its coding sequence
11/28/2001CN1323802A New human protein with the function of inhibiting cancer cell growth and its coding sequence
11/27/2001US6323396 Agrobacterium-mediated transformation of plants
11/27/2001US6323395 Gene expression; transcriptional terminator sequence
11/27/2001US6323394 Tissue culture process for producing a large number of viable mint plants in vitro
11/27/2001US6323393 Nucleotide sequences for use as tools in genetic engineering
11/27/2001US6323392 Formation of brassica napus F1 hybrid seeds which exhibit a highly elevated oleic acid content and a reduced linolenic acid content in the endogenously formed oil of the seeds
11/27/2001US6323391 Methods and transgenic mouse model for identifying and modulating factors leading to motor neuron degeneration
11/27/2001US6323390 Transgenic mouse models for human bladder cancer
11/27/2001US6323334 Nucleic acid molecules encoding a 103 gene product and uses therefor
11/27/2001US6323333 Mouse EDG1
11/27/2001US6323330 Protein C16 and C16N or genes encoding the same
11/27/2001US6323323 Ligand-binding, dimerized polypeptide fusions
11/27/2001US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/27/2001US6323317 Therapeutic and diagnostics proteins comprising a SOCS box
11/27/2001US6323185 Anti-viral guanosine-rich oligonucleotides and method of treating HIV
11/27/2001US6323184 Arteriovenous and venous graft treatments: methods and compositions
11/27/2001US6323180 Protease inhibitors; inhibit replication of hepatitis c virus
11/27/2001US6323178 Beta-lipotropin methods
11/27/2001US6323155 Excellent level of herbicidal activity together with crop tolerance
11/27/2001US6323031 Lentiviral vectors derived from SIVagm, methods for their preparation and their use for gene transfer into mammalian cells
11/27/2001US6323030 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
11/27/2001US6323029 Therapeutic, diagnostic, and research applications for the modulation of glycogen synthase kinase 3 beta expression
11/27/2001US6323028 Isolated peptides which comply with HLA-CW16 molecules and uses
11/27/2001US6323027 Common gamma chain monoclonal antibody blocking agents
11/27/2001US6323026 Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
11/27/2001US6323024 Plasmids for the expression of heterologus genes; for use in treatment and prevention of viral diseases
11/27/2001US6323023 Expression vector coding enzymatic polypeptides; for use in adjusting plant morphology
11/27/2001US6323020 Neutralization-sensitive epitopes of Cryptosporidium parvum
11/27/2001US6323019 Design of novel highly efficient HIV based packaging systems for gene therapy
11/27/2001US6323017 Enzymatic polypeptide for prevention and treatment of asthma, exudative tympanitis, hemorrhagic colitis and adult respiratory distress syndrome
11/27/2001US6323015 Sucrose phosphate synthase
11/27/2001US6323013 Lumazine synthase and riboflavin synthase
11/27/2001US6323011 Providing trans-ferulic acid or its salt; combining with enzyme activity i, enzyme activity ii, and enzyme activity iii, wherein enzyme activity i, enzyme activity ii, and enzyme activity iii catalyze the production of vanillin
11/27/2001US6323010 Providing substrates which comprise 2-hydroxybutyric acid in biological system which is genetically engineered to express one or more enzymes selected from the group consisting of polyhydroxyalkanoate synthase, acyl-coa transferase, etc.
11/27/2001US6323009 Multiply-primed amplification of nucleic acid sequences
11/27/2001US6323008 Methods for producing sialyloligosaccharides in a dairy source
11/27/2001US6323006 Recombinant human beta-CIS interferon
11/27/2001US6323005 Transferrin-binding protein 1 (TBP1) gene of Actinobacillus pleuropneumoniae, its use to prepare products for the utilization in vaccines for pleuropneumonia and as diagnostic reagents
11/27/2001US6323004 Modulation of polypeptide display on modified filamentous phage
11/27/2001US6323003 Compositions and methods for activating genes of interest
11/27/2001US6323002 Methods for modifying the production of a polypeptide
11/27/2001US6323001 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase
11/27/2001US6323000 To identify compounds that interact with it
11/27/2001US6322999 Cloned genes coding for human receptors, and cell lines expressing genes, in order to generate a proper screen for human therapeutic compounds
11/27/2001US6322997 Protein recovery
11/27/2001US6322995 Recombinant gram positive bacterium used for producing riboflavin
11/27/2001US6322990 Methods of identifying agents that block the interaction of a BAP protein with a signaling partner
11/27/2001US6322988 Providing sample of polynucleotide and selecting a region potentially containing variation; subjecting to template producing amplification reaction to produce double stranded polynucleotide templates; producing labelled fragments
11/27/2001US6322984 Methods involving nucleic acid molecules obtained from calcified microbial cells or material embedded in dental calculus of an animal
11/27/2001US6322983 Apparatus for the storage and prevention of degradation of nucleotide sequences
11/27/2001US6322980 Single nucleotide detection using degradation of a fluorescent sequence
11/27/2001US6322976 Compositions and methods of disease diagnosis and therapy
11/27/2001US6322974 Mitochondrial DNA damage as a predictor of coronary atherosclerotic heart disease
11/27/2001US6322973 Surrogate genetics target characterization method
11/27/2001US6322972 Detecting suppressors of ligand binding; transform cells, propagate cells, expose to modulator, compare expression of reporter genes in presence and absence of compound, decrease in expression indicates modulators
11/27/2001US6322971 Generating preferential genetically engineered products; provide immobilized oligonucleotides, hybridize single stranded nucleotide sequences to immobilized nucleotide sequences, recover products
11/27/2001US6322969 Method for preparing permuted, chimeric nucleic acid libraries
11/27/2001US6322968 Capture moiety, spacer region, and specific hybridization region which can hybridize to complementary sequence on template; wild-type genes
11/27/2001US6322965 Chimera antigen peptide
11/27/2001US6322795 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
11/27/2001US6322794 Seroreactive epitopes on proteins of human papillomavirus (HPV) 18
11/27/2001US6322793 Replacement of gene 50 glycoprotein with foreign genetic material
11/27/2001US6322792 Gamma-2 herpes viruses like kaposi's sarcoma-associated herpes virus useful in modulating persistence of heterologous dna; gene therapy
11/27/2001US6322791 Haemopoietic growth factor antagonists and uses therefor
11/27/2001US6322787 Induction of an anti-tumor immunity by redirecting tumor cells against antigen-presenting cells
11/27/2001US6322782 Bacterium NRRL B-30043 for controlling algae
11/27/2001US6322781 Production of recombinant baculoviruses
11/27/2001US6322780 Marek's disease virus vaccines for protection against Marek's disease
11/27/2001US6322779 Purified, unglycosylated endotoxin and pyrogen-free, high specific biological activity; two monomer structure
11/27/2001CA2240392C Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof
11/27/2001CA2178004C Indicator cell line for detecting rna viruses and method therefor
11/27/2001CA2145866C Human calcitonin receptor
11/27/2001CA2083286C Recombinant fibrinogenases, preparation and use thereof